Lista de obras -

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

artículo científico publicado en 2002

A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1)

scientific journal article

Acetylcholine Receptor Epitopes in Ocular Myastheniaa ⬇️

artículo científico publicado el 13 de mayo de 1998

An altered phenotype in a conditional knockout of Pitx2 in extraocular muscle

artículo científico publicado en 2009

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

artículo científico publicado en 2020

Cell surface complement regulators moderate experimental myasthenia gravis pathology

artículo científico publicado en 2012

Comparative analysis of therapeutic options used for myasthenia gravis

artículo científico publicado en 2010

Congenital disorders of neuromuscular transmission

artículo científico publicado en 1992

Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors

artículo científico publicado en 1999

Development of a Thymectomy Trial in Nonthymomatous Myasthenia Gravis Patients Receiving Immunosuppressive Therapy ⬇️

artículo científico publicado el 1 de septiembre de 2003

Differential susceptibility of the ocular motor system to disease.

artículo científico publicado en 2002

Disorders of neuromuscular junction ion channels

artículo científico publicado en 1999

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

artículo científico publicado en 2015

Effect of complement and its regulation on myasthenia gravis pathogenesis.

artículo científico publicado en 2008

Endocrine neuromyopathies ⬇️

artículo científico publicado el 1 de agosto de 1997

Evidence-based guideline update: Plasmapheresis in neurologic disorders ⬇️

artículo científico publicado el 25 de octubre de 2011

Extraocular muscle is defined by a fundamentally distinct gene expression profile

artículo científico publicado en 2001

Eye muscle sparing by the muscular dystrophies: lessons to be learned?

artículo científico publicado en 2000

Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles ⬇️

artículo científico publicado el 1 de septiembre de 2011

Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.

artículo científico publicado en 2018

Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1

artículo científico publicado en 2000

Implementing clinical trials on an international platform: challenges and perspectives

artículo científico publicado en 2011

Insights into Possible Skeletal Muscle Nicotinic Acetylcholine Receptor (AChR) Changes in Some Congenital Myasthenias from Physiological Studies, Point Mutations, and Subunit Substitutions of the AChRa ⬇️

artículo científico publicado el 21 de junio de 1993

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

artículo científico publicado en 2019

Medical and surgical treatment for ocular myasthenia

artículo científico publicado en 2012

Medical and surgical treatment for ocular myasthenia

artículo científico publicado en 2006

Molecular Organization of the Extraocular Muscle Neuromuscular Junction: Partial Conservation of and Divergence from the Skeletal Muscle Prototype ⬇️

artículo científico publicado el 1 de mayo de 2003

Monoclonal Antibody-Based Therapies for Myasthenia Gravis

artículo científico publicado en 2020

Monocular visual deprivation in macaque monkeys: a profile in the gene expression of lateral geniculate nucleus by laser capture microdissection

artículo científico publicado en 2008

Myasthenia gravis: past, present, and future

artículo científico publicado en 2006

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

artículo científico publicado en 2000

Myosin heavy chain expression in mouse extraocular muscle: more complex than expected

artículo científico publicado en 2010

Nitric oxide: biologic effects on muscle and role in muscle diseases

artículo científico publicado en 2001

Outcome of plasmapheresis in myasthenia gravis: Delayed therapy is not favorable ⬇️

artículo científico publicado el 1 de abril de 2011

Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibers

artículo científico publicado en 2009

Pitx2 regulates myosin heavy chain isoform expression and multi‐innervation in extraocular muscle ⬇️

artículo científico publicado el 4 de julio de 2011

Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes

artículo científico publicado en 2014

Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis

artículo científico publicado en 2012

RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment.

artículo científico publicado en 2014

Randomized Trial of Thymectomy in Myasthenia Gravis

artículo científico publicado en 2016

Recommendations for myasthenia gravis clinical trials

artículo científico publicado en 2012

Relation of aphemia and agraphia

artículo científico publicado el 1 de enero de 1992

Ritonavir-associated myasthenia gravis ⬇️

artículo científico publicado el 1 de mayo de 1998

Ryanodine receptor gene expression thymomas ⬇️

artículo científico publicado el 1 de octubre de 1998

Targeting therapy to the neuromuscular junction: proof of concept.

artículo científico publicado en 2014

Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis

artículo científico publicado en 2020

Transient neurologic deficit caused by chronic subdural hematoma ⬇️

artículo científico publicado el 1 de junio de 1992

Treatment of myasthenia gravis.

artículo científico publicado en 2011

Treatment of ocular myasthenia: steroids only when compelled

artículo científico publicado en 2000

Why are eye muscles frequently involved in myasthenia gravis? ⬇️

artículo científico publicado el 1 de noviembre de 1990

Lista de obras de

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1)

Acetylcholine Receptor Epitopes in Ocular Myastheniaa ⬇️

An altered phenotype in a conditional knockout of Pitx2 in extraocular muscle

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Cell surface complement regulators moderate experimental myasthenia gravis pathology

Comparative analysis of therapeutic options used for myasthenia gravis

Congenital disorders of neuromuscular transmission

Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors

Development of a Thymectomy Trial in Nonthymomatous Myasthenia Gravis Patients Receiving Immunosuppressive Therapy ⬇️

Differential susceptibility of the ocular motor system to disease.

Disorders of neuromuscular junction ion channels

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

Effect of complement and its regulation on myasthenia gravis pathogenesis.

Endocrine neuromyopathies ⬇️

Evidence-based guideline update: Plasmapheresis in neurologic disorders ⬇️

Extraocular muscle is defined by a fundamentally distinct gene expression profile

Eye muscle sparing by the muscular dystrophies: lessons to be learned?

Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles ⬇️

Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.

Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1

Implementing clinical trials on an international platform: challenges and perspectives

Insights into Possible Skeletal Muscle Nicotinic Acetylcholine Receptor (AChR) Changes in Some Congenital Myasthenias from Physiological Studies, Point Mutations, and Subunit Substitutions of the AChRa ⬇️

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Medical and surgical treatment for ocular myasthenia

Medical and surgical treatment for ocular myasthenia

Molecular Organization of the Extraocular Muscle Neuromuscular Junction: Partial Conservation of and Divergence from the Skeletal Muscle Prototype ⬇️

Monoclonal Antibody-Based Therapies for Myasthenia Gravis

Monocular visual deprivation in macaque monkeys: a profile in the gene expression of lateral geniculate nucleus by laser capture microdissection

Myasthenia gravis: past, present, and future

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

Myosin heavy chain expression in mouse extraocular muscle: more complex than expected

Nitric oxide: biologic effects on muscle and role in muscle diseases

Outcome of plasmapheresis in myasthenia gravis: Delayed therapy is not favorable ⬇️

Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibers

Pitx2 regulates myosin heavy chain isoform expression and multi‐innervation in extraocular muscle ⬇️

Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes

Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis

RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment.

Randomized Trial of Thymectomy in Myasthenia Gravis

Recommendations for myasthenia gravis clinical trials

Relation of aphemia and agraphia

Ritonavir-associated myasthenia gravis ⬇️

Ryanodine receptor gene expression thymomas ⬇️

Targeting therapy to the neuromuscular junction: proof of concept.

Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis

Transient neurologic deficit caused by chronic subdural hematoma ⬇️

Treatment of myasthenia gravis.

Treatment of ocular myasthenia: steroids only when compelled

Why are eye muscles frequently involved in myasthenia gravis? ⬇️